Shimadzu Biotech today introduced the AXIMA-TOF2™, its new high-performance MALDI TOF-TOF mass spectrometer. Representing the next generation in high-energy collision induced dissociation (CID) MS/MS instrumentation, the AXIMA-TOF2 brings enhanced flexibility to Life Science laboratories, significantly extending the type of analyses they can provide. The device was introduced at the 54th American Society for Mass Spectrometry Conference in Seattle.
